CIK 0000318154 · Large accelerated filer
AMGEN INC
Sign in to watch- Ticker
- AMGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 953540776
- Phone
- (805)447-1000
- Business address
- ONE AMGEN CENTER DRIVE, THOUSAND OAKS, CA, 91320
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-05 | Bradway Robert A Chairman, CEO and President | Grant or award · Nqso (Right to Buy) | +79,176 | $329.59 | $26.1M | 79,176 |
| 2026-05-05 | Busch Matthew C. VP, Finance & CAO | Grant or award | +455 | 4,435 | ||
| 2026-05-05 | Busch Matthew C. VP, Finance & CAO | Grant or award · Nqso (Right to Buy) | +2,969 | $329.59 | $979K | 2,969 |
| 2026-05-05 | Gordon Murdo EVP, Global Commercial Ops | Grant or award | +3,640 | 52,339 | ||
| 2026-05-05 | Gordon Murdo EVP, Global Commercial Ops | Grant or award · Nqso (Right to Buy) | +23,752 | $329.59 | $7.8M | 23,752 |
| 2026-05-05 | Graham Jonathan P EVP & Gen. Counsel & Sec. | Grant or award | +2,609 | 40,619 | ||
| 2026-05-05 | Graham Jonathan P EVP & Gen. Counsel & Sec. | Grant or award · Nqso (Right to Buy) | +17,022 | $329.59 | $5.6M | 17,022 |
| 2026-05-05 | Griffith Peter H. EVP & CFO | Grant or award | +3,640 | 51,208 | ||
| 2026-05-05 | Griffith Peter H. EVP & CFO | Grant or award · Nqso (Right to Buy) | +23,752 | $329.59 | $7.8M | 23,752 |
| 2026-05-05 | Grygiel Nancy A. SVP & CCO | Grant or award | +485 | 7,494 | ||
| 2026-05-05 | Grygiel Nancy A. SVP & CCO | Grant or award · Nqso (Right to Buy) | +3,167 | $329.59 | $1.0M | 6,334 |
| 2026-05-05 | Khosla Rachna SVP, Business Development | Grant or award | +500 | 8,566 | ||
| 2026-05-05 | Khosla Rachna SVP, Business Development | Grant or award · Nqso (Right to Buy) | +3,266 | $329.59 | $1.1M | 3,266 |
| 2026-05-05 | Miller Derek SVP, Human Resources | Grant or award | +910 | 12,718 | ||
| 2026-05-05 | Miller Derek SVP, Human Resources | Grant or award · Nqso (Right to Buy) | +5,938 | $329.59 | $2.0M | 5,938 |
| 2026-05-05 | REESE DAVID M EVP & Chief Technology Officer | Grant or award | +2,912 | 43,266 | ||
| 2026-05-05 | REESE DAVID M EVP & Chief Technology Officer | Grant or award · Nqso (Right to Buy) | +19,002 | $329.59 | $6.3M | 19,002 |
| 2026-05-05 | Santos Esteban EVP, Operations | Grant or award | +2,730 | 83,796 | ||
| 2026-05-05 | Santos Esteban EVP, Operations | Grant or award · Nqso (Right to Buy) | +17,814 | $329.59 | $5.9M | 17,814 |
| 2026-05-05 | ISHRAK OMAR Director | Grant or award | +106.19 | 6,693.74 |
Page 4 of 22 · 430 trades